IGF2 and glioblastoma: On the basis of our findings, we propose that GBM tumor growth is characterized by a structured population with less aggressive clones (TMZ-sensitive-IGFBP6+-IFG-1R−) that block the expansion of more aggressive cells (TMZ-resistant-IGF2+IGF-1R+).